Yamada Kanae, Zhong Xiaoling, Kanazawa Shinsaku, Koike Junichi, Tsujita Kazunori, Hemmi Hiromichi
Department of Molecular Biology, Toho University School of Medicine, 5-21-16 Ohmori-Nishi, Ohta-ku, Tokyo 143-8540, Japan.
Oncol Rep. 2003 Jul-Aug;10(4):859-66.
The deficiency of the DNA mismatch repair (MMR) system is involved in tumorigenesis of either familial or sporadic colorectal cancers showing microsatellite instability (MSI). To investigate the involvement of the mutated hMSH2 gene in carcinogenesis, we searched for alteration of the gene in 15 MSI tumors of Japanese patients with sporadic colorectal cancer by a polymerase chain reaction (PCR)-single strand conformation polymorphism (SSCP) and DNA sequencing analyses. We found 20 alterations including 7 novel mutations, 6 germline and one somatic. To assume an oncogenic pathway of tumor of two patients carrying germline missense mutations, G40S located in an evolutionarily conserved amino-terminal motif and Y619C in a domain interacting with either hMSH3 or hMSH6, somatic mutations in 9 target genes of the MMR defect and in the p53 and K-ras genes and loss of heterozygosity (LOH) at the hMLH1 and p53 gene loci were then studied. In the tumor carrying G40S, other somatic hMSH2 mutations, G203R and 687delA in the (A)(7) repeat, and 5 one-bp deletions in the target genes were found, while no mutation in the p53 and K-ras genes. These results indicate that G40S may affect the hMSH2 function and the tumor may be developed by a typical MSI pathway. In another tumor with Y619C, LOH at the hMLH1 gene locus, no mutation in MMR target genes, and two-hit inactivation of the p53 gene were detected. This MSI tumor seems to be developed by another than MSI pathway. These results indicate that there are different oncogenic pathways in the MSI sporadic colorectal cancers with germline missense mutations in the hMSH2 gene. We conclude that familial colorectal cancer-suspected cases exist in a small population of sporadic colorectal cancers.
DNA错配修复(MMR)系统缺陷与显示微卫星不稳定性(MSI)的家族性或散发性结直肠癌的肿瘤发生有关。为了研究突变的hMSH2基因在致癌作用中的参与情况,我们通过聚合酶链反应(PCR)-单链构象多态性(SSCP)和DNA测序分析,在15例日本散发性结直肠癌MSI肿瘤患者中寻找该基因的改变。我们发现了20种改变,包括7种新突变、6种胚系突变和1种体细胞突变。为了推测两名携带胚系错义突变患者肿瘤的致癌途径,研究了位于进化保守的氨基末端基序中的G40S和与hMSH3或hMSH6相互作用的结构域中的Y619C,MMR缺陷的9个靶基因以及p53和K-ras基因中的体细胞突变以及hMLH1和p53基因位点的杂合性缺失(LOH)。在携带G40S的肿瘤中,发现了其他体细胞hMSH2突变、(A)(7)重复序列中的G203R和687delA以及靶基因中的5个单碱基缺失,而p53和K-ras基因未发现突变。这些结果表明G40S可能影响hMSH2功能,肿瘤可能通过典型的MSI途径发生。在另一例携带Y619C的肿瘤中,检测到hMLH1基因位点的LOH、MMR靶基因无突变以及p53基因的双打击失活。这种MSI肿瘤似乎通过不同于MSI的途径发生。这些结果表明,在hMSH2基因存在胚系错义突变的MSI散发性结直肠癌中存在不同的致癌途径。我们得出结论,在一小部分散发性结直肠癌患者中存在疑似家族性结直肠癌病例。